**11 Children’s Deaths: Drug Watchdog Urges Strict Action Against Coldrif**

*By Snehil Singh | Oct 05, 2025, 11:11 am*

The Central Drugs Standard Control Organisation (CDSCO) is gearing up to take stringent action against the manufacturers of Coldrif syrup following the tragic deaths of 11 children, allegedly due to contaminated cough syrups.

The CDSCO has directed the Tamil Nadu Food and Drug Administration (FDA) to initiate strict measures under serious offense regulations, according to a report by news agency ANI.

### National Conference and Government Response

In response to this crisis, the Union Health Secretary is set to hold a video conference with health officials from all states and Union Territories. The meeting’s objective is to discuss the rational use of cough syrups and enforce drug quality standards nationwide.

This step comes after the deaths of 11 children in Madhya Pradesh and Rajasthan were linked to the consumption of contaminated cough syrups, raising serious concerns about drug safety.

### Ongoing Investigation and Risk-Based Inspections

The CDSCO has launched risk-based inspections of drug manufacturing units across six states — Himachal Pradesh, Uttarakhand, Gujarat, Tamil Nadu, Madhya Pradesh, and Maharashtra. Investigators have collected 19 samples from these states for thorough testing.

A multidisciplinary team of experts is currently analyzing the samples to pinpoint the exact cause behind the deaths reported in Chhindwara, Madhya Pradesh.

### Sample Analysis and Findings

Earlier this week, the CDSCO confirmed that six samples tested by them, along with three from the Madhya Pradesh Food and Drugs Administration, were free from toxic compounds such as Diethylene Glycol (DEG) and Ethylene Glycol (EG). These substances are known to cause severe kidney damage.

However, it was clarified that the tested samples did not include the two suspicious cough syrups, including Coldrif, which remain under scrutiny.

### Regional Actions Against Coldrif Syrup

In light of these developments, several states have taken proactive measures against Coldrif syrup. Kerala, Tamil Nadu, and Madhya Pradesh have imposed bans on its sale. Telangana has issued a public alert urging people to stop using the product immediately.

These actions are part of broader efforts to ensure drug safety and uphold quality standards across India, following the heartbreaking loss of children linked to contaminated cough syrups.

The investigation is ongoing, and authorities continue to monitor the situation closely to prevent further casualties.
https://www.newsbytesapp.com/news/india/drug-watchdog-urges-strict-action-against-coldrif-makers-report/story

**11 Children’s Deaths: Drug Watchdog Urges Strict Action Against Coldrif**

*By Snehil Singh | Oct 05, 2025, 11:11 AM*

The Central Drugs Standard Control Organisation (CDSCO) is set to take stringent action against the manufacturers of Coldrif syrup following the tragic deaths of 11 children, allegedly caused by contaminated cough syrups.

According to reports from ANI, the CDSCO has directed the Tamil Nadu Food and Drug Administration (FDA) to initiate strict measures under serious offense provisions to tackle this grave issue.

—

**Union Health Secretary to Convene National Conference**

In response to the crisis, the Union Health Secretary will conduct a video conference with health officials from all states and Union Territories. The discussion will focus on the rational use of cough syrups and enforcing drug quality standards nationwide.

This move follows the deaths of 11 children in Madhya Pradesh and Rajasthan, which have been linked to contaminated cough syrups.

—

**Ongoing Investigations and Inspections**

The CDSCO has launched risk-based inspections targeting drug manufacturing units across six states: Himachal Pradesh, Uttarakhand, Gujarat, Tamil Nadu, Madhya Pradesh, and Maharashtra.

Authorities have collected 19 samples from these regions for comprehensive testing. A multidisciplinary team of experts is currently analyzing the samples to uncover the cause behind the fatalities in Chhindwara, Madhya Pradesh.

—

**Sample Analysis Results**

Earlier this week, the CDSCO confirmed that six of its tested samples, along with three from the Madhya Pradesh Food and Drugs Administration, were free from toxic compounds such as Diethylene Glycol (DEG) and Ethylene Glycol (EG). These chemicals are notorious for causing severe kidney damage.

However, officials clarified that these tested samples did not include the two cough syrups under suspicion, including Coldrif.

—

**Regional Actions Against Coldrif Syrup**

In light of the findings, several states have taken immediate action against Coldrif syrup. Kerala, Tamil Nadu, and Madhya Pradesh have imposed bans on its sale. Meanwhile, Telangana has issued a public alert advising citizens to discontinue use of the product.

These measures are part of a larger effort to ensure drug safety and quality across India, following the heartbreaking loss of young lives allegedly linked to contaminated cough syrups.

—

*Stay tuned for further updates on this developing story.*
https://www.newsbytesapp.com/news/india/drug-watchdog-urges-strict-action-against-coldrif-makers-report/story

**11 Children’s Deaths: Drug Watchdog Urges Strict Action Against Coldrif**

*By Snehil Singh | Oct 05, 2025, 11:11 AM*

—

The Central Drugs Standard Control Organisation (CDSCO) is set to take stringent action against the manufacturers of Coldrif syrup following the tragic deaths of 11 children, allegedly caused by contaminated cough syrups.

According to reports from ANI, the CDSCO has directed the Tamil Nadu Food and Drug Administration (FDA) to initiate strict measures under serious offenses to address the issue.

**National Conference to Address Drug Safety**

In response to the incident, the Union Health Secretary will conduct a video conference with health officials from all states and Union Territories. The meeting aims to discuss the rational use of cough syrups and enhance drug quality standards across India.

This initiative comes amid investigations linking the deaths of 11 children in Madhya Pradesh and Rajasthan to contaminated cough syrups.

**Ongoing Investigation and Risk-Based Inspections**

The CDSCO has commenced risk-based inspections of drug manufacturing units in six states: Himachal Pradesh, Uttarakhand, Gujarat, Tamil Nadu, Madhya Pradesh, and Maharashtra.

Authorities have collected 19 samples from these regions for comprehensive testing. A multidisciplinary team of experts is currently analyzing these samples to determine the cause of fatalities in Chhindwara, Madhya Pradesh.

**Sample Analysis Results**

Earlier this week, the CDSCO confirmed that six tested samples, along with three from the Madhya Pradesh Food and Drugs Administration, were free from toxic compounds such as Diethylene Glycol (DEG) and Ethylene Glycol (EG). These substances are known to cause severe kidney damage.

However, officials noted that these tested samples did not include the two cough syrups currently under scrutiny, including Coldrif.

**Regional Actions Taken**

Following the CDSCO’s findings, several states have taken decisive steps against Coldrif syrup. Kerala, Tamil Nadu, and Madhya Pradesh have banned the sale of the product.

Meanwhile, Telangana has issued a public alert advising people to stop using Coldrif syrup immediately.

These actions form part of a broader effort to safeguard drug safety and quality in India after the unfortunate deaths linked to contaminated cough syrups.

—

*Stay tuned for updates on this developing story.*
https://www.newsbytesapp.com/news/india/drug-watchdog-urges-strict-action-against-coldrif-makers-report/story